Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Alonso

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
Nature Communications|September 17, 2021
Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancerJing Li, Shunya Ohmura, Aruna Marchetto, et al.
American Journal of Medical Genetics. Part A|December 21, 2020
De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defectsBeatriz Martinez-Delgado, Estrella Lopez-Martin, Julián Lara-Herguedas, et al.
JAMA Dermatology|September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical TrialsEric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
JAMA Dermatology|June 25, 2025
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical TrialAndrew Alexis, Amy McMichael, Jennifer Soung, et al.
Nature Genetics|February 14, 2012
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSophie Postel-Vinay, Amélie S Véron, Franck Tirode, et al.
Scientific Reports|September 20, 2017
DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated DisordersMaría Berdasco, Antonio Gómez, Marcos J Rubio, et al.
JAMA Dermatology|May 3, 2023
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical TrialMatthew J Zirwas, Zoe D Draelos, Janet DuBois, et al.
Cancer Letters|November 30, 2016
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1Juan Huertas-Martínez, Franck Court, Santiago Rello-Varona, et al.
Ebiomedicine|August 21, 2019
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patientsGiuseppina Sannino, Aruna Marchetto, Andreas Ranft, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
Nature Communications|September 17, 2021
Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancerJing Li, Shunya Ohmura, Aruna Marchetto, et al.
American Journal of Medical Genetics. Part A|December 21, 2020
De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defectsBeatriz Martinez-Delgado, Estrella Lopez-Martin, Julián Lara-Herguedas, et al.
JAMA Dermatology|September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical TrialsEric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
JAMA Dermatology|June 25, 2025
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical TrialAndrew Alexis, Amy McMichael, Jennifer Soung, et al.
Nature Genetics|February 14, 2012
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSophie Postel-Vinay, Amélie S Véron, Franck Tirode, et al.
Scientific Reports|September 20, 2017
DNA Methylomes Reveal Biological Networks Involved in Human Eye Development, Functions and Associated DisordersMaría Berdasco, Antonio Gómez, Marcos J Rubio, et al.
JAMA Dermatology|May 3, 2023
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical TrialMatthew J Zirwas, Zoe D Draelos, Janet DuBois, et al.
Cancer Letters|November 30, 2016
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1Juan Huertas-Martínez, Franck Court, Santiago Rello-Varona, et al.
Ebiomedicine|August 21, 2019
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patientsGiuseppina Sannino, Aruna Marchetto, Andreas Ranft, et al.
Pageof 27